These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37955291)

  • 1. [New guidelines on the diagnostic and therapeutic management of hypertrophic cardiomyopathy].
    Lancellotti P; Masson A; Damas F; de Marneffe N
    Rev Med Liege; 2023 Nov; 78(11):619-625. PubMed ID: 37955291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?].
    Maisch B; Mahrholdt H;
    Herz; 2014 Dec; 39(8):919-30. PubMed ID: 25410471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic evaluation of hypertrophic cardiomyopathy in its clinical and preclinical phases.
    Mattos BP; Torres MA; Freitas VC
    Arq Bras Cardiol; 2008 Jul; 91(1):51-62. PubMed ID: 18660946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine.
    Monda E; Bakalakos A; Rubino M; Verrillo F; Diana G; De Michele G; Altobelli I; Lioncino M; Perna A; Falco L; Palmiero G; Elliott PM; Limongelli G
    Circ Heart Fail; 2023 Aug; 16(8):e010687. PubMed ID: 37477018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of cardiomyopathies : New ESC guidelines 2023].
    Pavo N; Hengstenberg C
    Herz; 2024 Feb; 49(1):22-32. PubMed ID: 38051386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy.
    Maron BJ; Seidman CE; Ackerman MJ; Towbin JA; Maron MS; Ommen SR; Nishimura RA; Gersh BJ
    Circ Cardiovasc Genet; 2009 Feb; 2(1):81-5; discussion 86. PubMed ID: 20031569
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
    Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnosis of idiopathic cardiomyopathy from ischemic cardiomyopathy and hypertensive heart disease using non-invasive methods].
    Masuda Y
    Nihon Rinsho; 2000 Jan; 58(1):218-22. PubMed ID: 10885317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis.
    Spirito P; Autore C
    Eur Heart J; 2007 Aug; 28(16):1923-4. PubMed ID: 17623677
    [No Abstract]   [Full Text] [Related]  

  • 11. Left ventricular hypertrophy diagnosed after a stroke: a case report.
    Umeojiako WI; Kanyal R
    J Med Case Rep; 2018 Mar; 12(1):76. PubMed ID: 29562910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.
    Maron BJ
    Ann Noninvasive Electrocardiol; 2001 Oct; 6(4):277-9. PubMed ID: 11686906
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing Demographics in Hypertrophic Cardiomyopathy and Implications for Management: Clinical Research.
    Maron BJ; Rowin EJ; Ambe SP; Maron MS
    Am J Med; 2022 Oct; 135(10):1244-1246. PubMed ID: 35649468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy.
    Weissler-Snir A; Crean A; Rakowski H
    Expert Rev Cardiovasc Ther; 2016; 14(1):51-74. PubMed ID: 26567960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
    Bahl A
    Indian Heart J; 2008; 60(3):273. PubMed ID: 19240323
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy: diagnosis and therapeutic options.
    Gluckman TJ
    Am J Manag Care; 2021 Apr; 27(6 Suppl):S111-S117. PubMed ID: 33861535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fuzzy diagnostic boundaries among left ventricular outflow tract obstruction in hypertensive hypertrophy, hypertrophic cardiomyopathy, and Takotsubo syndrome.
    Madias JE
    Int J Cardiol; 2015 Oct; 197():10. PubMed ID: 26134368
    [No Abstract]   [Full Text] [Related]  

  • 18. [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].
    ; Elliott PM; Anastasakis A; Borger MA; Borggrefe M; Cecchi F; Charron P; Hagege AA; Lafont A; Limongelli G; Mahrholdt H; McKenna WJ; Mogensen J; Nihoyannopoulos P; Nistri S; Pieper PG; Pieske B; Rapezzi C; Rutten FH; Tillmanns C; Watkins H
    Kardiol Pol; 2014; 72(11):1054-126. PubMed ID: 25524376
    [No Abstract]   [Full Text] [Related]  

  • 19. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
    Bahl A
    Indian Heart J; 2007; 59(4):382. PubMed ID: 19126950
    [No Abstract]   [Full Text] [Related]  

  • 20. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.